In recent trading session, Rockwell Medical Inc (NASDAQ:RMTI) saw 1.11 million shares changing hands at last check today with its beta currently measuring 1.17. Company’s recent per share price level of $1.66 trading at $0.01 or 0.61% at last check today assigns it a market valuation of $47.29M. That most recent trading price of RMTI’s stock is at a discount of -275.9% from its 52-week high price of $6.24 and is indicating a premium of 30.12% from its 52-week low price of $1.16. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.22 million shares which gives us an average trading volume of 211.98K if we extend that period to 3-months.
Rockwell Medical Inc (NASDAQ:RMTI) trade information
Upright in the green today for gaining 0.61%, in the last five days RMTI remained trading in the green while hitting it’s week-highest on Thursday, 03/21/24 when the stock touched $1.66 price level, adding 5.14% to its value on the day. Rockwell Medical Inc’s shares saw a change of -12.17% in year-to-date performance and have moved 19.42% in past 5-day. Rockwell Medical Inc (NASDAQ:RMTI) showed a performance of 24.81% in past 30-days. Number of shares sold short was 0.63 million shares which calculate 3.63 days to cover the short interests.
Rockwell Medical Inc (RMTI) estimates and forecasts
Statistics highlight that Rockwell Medical Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -12.63% of value to its shares in past 6 months, showing an annual growth rate of 78.84% while that of industry is 17.90. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 65.00% in the current quarter and calculating 40.00% increase in the next quarter. This year revenue growth is estimated to rise 15.60% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $22.63 million for the same. And 2 analysts are in estimates of company making revenue of $23.8 million in the next quarter that will end on Mar 2024. Company posted $19.31 million and $19.12 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 17.20% while estimating it to be 24.50% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 19.45% during past 5 years.
RMTI Dividends
Rockwell Medical Inc is more likely to be releasing its next quarterly report on March 21 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Rockwell Medical Inc (NASDAQ:RMTI)’s Major holders
Insiders are in possession of 3.09% of company’s total shares while institution are holding 18.01 percent of that, with stock having share float percentage of 18.59%. Investors also watch the number of corporate investors in a company very closely, which is 18.01% institutions for Rockwell Medical Inc that are currently holding shares of the company. Armistice Capital, LLC is the top institutional holder at RMTI for having 1.85 million shares of worth $3.04 million. And as of Dec 30, 2023, it was holding 6.50% of the company’s outstanding shares.
The second largest institutional holder is Vanguard Group Inc, which was holding about 1.07 million shares on Dec 30, 2023. The number of shares represents firm’s hold over 3.77% of outstanding shares, having a total worth of $1.76 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 30, 2023, the former fund manager was holding 0.76 million shares of worth $1.25 million or 2.67% of the total outstanding shares. The later fund manager was in possession of 0.31 million shares on Dec 30, 2023, making its stake of worth around $0.51 million in the company or a holder of 1.10% of company’s stock.
